Eric D. Weinhandl
A5078004794- Dialysis and Renal Disease Management
- Central Venous Catheters and Hemodialysis
- Healthcare Policy and Management
- Healthcare cost, quality, practices
- Renal Transplantation Outcomes and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Organ Donation and Transplantation
- Chronic Kidney Disease and Diabetes
- Pharmacological Effects and Toxicity Studies
- Heart Failure Treatment and Management
- Erythropoietin and Anemia Treatment
- Blood Pressure and Hypertension Studies
- Diabetes Treatment and Management
- Renal and Vascular Pathologies
- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Pregnancy and Medication Impact
- Geriatric Care and Nursing Homes
- Parathyroid Disorders and Treatments
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Iron Metabolism and Disorders
- Hemoglobinopathies and Related Disorders
- Acute Kidney Injury Research
- Muscle and Compartmental Disorders
Hennepin Healthcare Research Institute
2020-2024
Satellite Healthcare (United States)
2022-2024
University of Minnesota
2014-2024
DaVita Clinical Research (United States)
2023-2024
Twin Cities Orthopedics
2021-2024
Hennepin County Medical Center
2006-2022
Metro-Minnesota Community Oncology Research Consortium
2007-2022
Fresenius Medical Care North America (United States)
2019-2021
Fresenius Medical Care (United States)
2019-2021
Fresenius Medical Care (Germany)
2020
Contemporary comparisons of mortality in matched hemodialysis and peritoneal dialysis patients are lacking. We aimed to compare survival incident by intention-to-treat analysis a matched-pair cohort subsets defined age, cardiovascular disease, diabetes. 6337 patient pairs from retrospective 98,875 adults who initiated 2003 the United States. In primary day 0, cumulative was higher for than (hazard ratio 0.92; 95% CI 0.86 1.00, P = 0.04). Cumulative probabilities versus were 85.8% 80.7% (P <...
Background: The prevalence of metastatic bone disease in the US population is not well understood. We sought to estimate current number adults with using two large administrative data sets. Methods: Prevalence was estimated from a commercially insured cohort (ages 18–64 years, MarketScan database) and fee-for-service Medicare ≥65 5% coverage on December 31, 2008, representing approximately two-thirds each age group. searched for claims-based evidence January 1, 2004, combination relevant...
Home dialysis modalities (home hemodialysis [HD] and peritoneal [PD]) are associated with greater patient autonomy treatment satisfaction compared in-center modalities, yet the level of home-dialysis use worldwide is low. Reasons for limited utilization context-dependent, informed by local resources, costs, access to healthcare, health system policies, provider bias or preferences, cultural beliefs, individual lifestyle concerns, potential care-partner time, financial burdens. In May 2021,...
Frequent hemodialysis improves cardiovascular surrogates and quality-of-life indicators, but its effect on survival remains unclear. We used a matched-cohort design to assess relative mortality in daily home thrice-weekly in-center patients between 2005 2008. matched 1873 with 9365 (i.e., 1:5 ratio) selected from the prevalent population US Renal Data System database. Matching variables included first date of follow-up, demographic characteristics, measures disease severity. The cumulative...
Awareness of hemoglobin level variability in dialysis patients is increasing, as interest its potential implications. In this retrospective, national study associations between the degree first 6 mo 2004 and subsequent mortality rates following mo, 159,720 hemodialysis receiving epoetin therapy were studied.Monthly values categorized low (L; < 11 g/dl), intermediate (I; to 12.5 high (H; >12.5 g/dl). Variability groups classified on basis lowest highest categories seen during 6-mo observation...
Use of home dialysis is growing in the United States, but few direct comparisons major clinical outcomes on daily hemodialysis (HHD) versus peritoneal (PD) exist.Matched cohort study.We matched 4,201 new HHD patients 2007 to 2010 with PD from US Renal Data System database.Daily PD.Relative mortality, hospitalization, and technique failure.Mean time end-stage renal disease onset therapy initiation was 44.6 months for 44.3 patients. In intention-to-treat analysis, associated 20% lower risk...